# Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms

Study · id `cardio:ct-nct07372612` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07372612](<https://clinicaltrials.gov/study/NCT07372612>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07372612

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.

## Technical summary

Registry record NCT07372612. Randomized; no masking; primary purpose treatment. Start 2026-01-20 (anticipated); primary completion 2027-10-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT07372612, source copy `cardio:ctgov-nct07372612-2026-01-28`, retrieved 2026-11-18)
- Planned start: 2026-01-20 (anticipated) (ClinicalTrials.gov record NCT07372612, source copy `cardio:ctgov-nct07372612-2026-01-28`, retrieved 2026-11-18)
- Primary completion: 2027-10-15 (anticipated) (ClinicalTrials.gov record NCT07372612, source copy `cardio:ctgov-nct07372612-2026-01-28`, retrieved 2026-11-18)
- Completion: 2028-10-15 (anticipated) (ClinicalTrials.gov record NCT07372612, source copy `cardio:ctgov-nct07372612-2026-01-28`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07372612-2026-01-28`, retrieved 2026-11-18)

## The registry's words

- Brief title: Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms
- Condition: Aneurysms
- Condition: Flow Diverter
- Condition: Middle Cerebral Artery Aneurysm
- Condition: Coiling Therapy
- Intervention (Procedure): Flow diverter
- Intervention (Procedure): Stent-assisted coiling
- Lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as the lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (`cardio:org-the-affiliated-nanjing-drum-tower-hospital-of-nanjing-3a906f`)

## Provenance

Content hash: 48239e8fc056c1a0cb757b664a12afa590839b4bdbad61b220c8c17990a6b9a5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
